4.6 Review

Lipoprotein lipase: From gene to atherosclerosis

期刊

ATHEROSCLEROSIS
卷 237, 期 2, 页码 597-608

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2014.10.016

关键词

LPL; Lipoprotein; Lipid; Triglyceride; Inflammation; Atherosclerosis

资金

  1. National Natural Science Foundation of China [81270269, 81170278, 81370377, 81300158, 81300224]
  2. Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province, China [2008-244]
  3. construct program of the key discipline in Hunan Province

向作者/读者索取更多资源

Lipoprotein lipase (LPL) is a key enzyme in lipid metabolism and responsible for catalyzing lipolysis of triglycerides in lipoproteins. LPL is produced mainly in adipose tissue, skeletal and heart muscle, as well as in macrophage and other tissues. After synthesized, it is secreted and translocated to the vascular lumen. LPL expression and activity are regulated by a variety of factors, such as transcription factors, interactive proteins and nutritional state through complicated mechanisms. LPL with different distributions may exert distinct functions and have diverse roles in human health and disease with close association with atherosclerosis. It may pose a pro-atherogenic or an anti-atherogenic effect depending on its locations. In this review, we will discuss its gene, protein, synthesis, transportation and biological functions, and then focus on its regulation and relationship with atherosclerosis and potential underlying mechanisms. The goal of this review is to provide basic information and novel insight for further studies and therapeutic targets. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据